HAEMONETICS CORP
For the period ended Mar 28, 2026. Filed May 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 20, 2026
HAE$118.21-1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
During the three months ended March 28, 2026, none of our directors or officers (as defined under Rule 16a-1(f) under the Securities Exchange Act of 1934)adopted orterminated trading arrangements for the sale of shares of our common stock.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.